AIM
MRVI icon

Arcadia Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Arcadia Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-975
Closed -$25K – 353
2022
Q3 		$25K Hold
975
– – 0.01% 219
2022
Q2 		$28K Hold
975
– – 0.01% 221
2022
Q1 		$34K Hold
975
– – 0.01% 222
2021
Q4 		$41K Buy
+975
New +$39.5K 0.01% 220

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Arcadia Investment Management's MRVI Position: Q4 2022 in Review

Arcadia Investment Management sold out of Maravai LifeSciences (MRVI) in Q4 2022, closing a stake of 975 shares — an estimated $25K sold.

Arcadia Investment Management first reported a position in MRVI in Q4 2021 and held it in 4 quarters. The position peaked at $41K in Q4 2021. 212 funds tracked by Wall St. Rank hold MRVI as of Q4 2022.

  • Arcadia Investment Management reported no remaining Maravai LifeSciences position as of Q4 2022 after selling out during the quarter.
  • Arcadia Investment Management sold 975 Maravai LifeSciences shares in Q4 2022, an estimated $25K.
  • Arcadia Investment Management first reported a position in Maravai LifeSciences in Q4 2021 and held it in 4 quarters.
  • Arcadia Investment Management's Maravai LifeSciences position peaked at $41K in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2022.

Based on Arcadia Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.